Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Stomatitis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Papillomavirus Infections 1Ovarian Neoplasms 1Mucositis 1Lung Neoplasms 1Hyperbilirubinemia 1Folic Acid Deficiency 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Specimen Handling 7Radiotherapy, Intensity-Modulated 5Human Papillomavirus Recombinant Vaccine nonavalent 5Human Papillomavirus DNA Tests 5Colposcopy 5Cisplatin 5Patient Navigation 3Methods 3Early Intervention, Educational 3Carboplatin 3human papillomavirus vaccine, L1 type 16, 18 2epigallocatechin gallate 2artesunic acid 2artemisinin 2Standard of Care 2Practice Guidelines as Topic 2Papillomavirus Vaccines 2Mass Screening 2Educational Status 2Docetaxel 2Cytological Techniques 2Blood Specimen Collection 2toripalimab 1fludarabine phosphate 1fludarabine 1artenimol 1aldesleukin 1adacel 1Watchful Waiting 1Vitamin B 12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Papillomavirus Infections × Folic Acid × 1 year × Clear all
NCT06285357 2025-11-20

The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

Lo.Li.Pharma s.r.l

Phase NA Recruiting
100 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡